38 indexed places to earn across crypto and traditional venues. Compare facts, inspect the evidence, then choose for yourself.
| Opportunity | Published APY | Liquidity | Access | Last checked | Evidence | Actions |
|---|---|---|---|---|---|---|
GHO-FXUSD convex-finance · LPs & Vaults · ethereum | 0.07% | $109K | Open access | Oct 8, 2026 | UnratedEvidence incomplete — 37% confidence · +2 more
| |
GHO-USDC (0.3%) uniswap-v3 · LPs & Vaults · base | 10.9% | $54K | Open access | Oct 8, 2026 | UnratedEvidence incomplete — 37% confidence · +2 more
| |
GHO-CRVUSD convex-finance · LPs & Vaults · ethereum | 7.28% | $1.2M | Open access | Oct 8, 2026 | UnratedEvidence incomplete — 37% confidence · +1 more
| |
GHO-USDC (0.01%) uniswap-v3 · LPs & Vaults · ethereum | 0.92% | $293K | Open access | Oct 7, 2026 | UnratedEvidence incomplete — 37% confidence · +3 more
| |
GHO-USDE curve-dex · LPs & Vaults · ethereum | 0.17% | $44K | Open access | Oct 5, 2026 | UnratedEvidence incomplete — 37% confidence · +3 more
| |
GHO-USDC (0.05%) uniswap-v3 · LPs & Vaults · arbitrum | 1.14% | $32K | Open access | Oct 1, 2026 | UnratedEvidence incomplete — 37% confidence · +3 more
| |
GHO-USDT (0.01%) uniswap-v4 · LPs & Vaults · ethereum | 28.8% Elevated rate | $396K | Open access | Sep 30, 2026 | UnratedEvidence incomplete — 32% confidence · +4 more
| |
SURGEAAVEEURC-GHO balancer-v3 · LPs & Vaults · base | 15.8% | $28K | Open access | Sep 30, 2026 | UnratedEvidence incomplete — 32% confidence · +4 more
| |
GHO-USDC (0.05%) uniswap-v4 · LPs & Vaults · ethereum | 0.03% | $3.0M | Open access | Sep 14, 2026 | UnratedEvidence incomplete — 32% confidence · +3 more
| |
GHO-USDC (0.05%) uniswap-v4 · LPs & Vaults · base | 3.29% | $54K | Open access | Jul 30, 2026 | UnratedEvidence incomplete — 32% confidence · +4 more
| |
GHO-USDC (0.05%) uniswap-v3 · LPs & Vaults · ethereum | 4.13% | $225K | Open access | Jun 19, 2026 | UnratedEvidence incomplete — 37% confidence · +4 more
|
Rates can change at any time. StableLens does not custody assets or execute transactions. A listing is not an endorsement, and Unrated means the evidence is incomplete—not that the opportunity is neutral-risk.
